Worthmann, H.; Dengler, R.; Schumacher, H.; Schwartz, A.; Eisert, W.G.; Lichtinghagen, R.; Weissenborn, K.
Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke. Int. J. Mol. Sci. 2012, 13, 8670-8678.
https://doi.org/10.3390/ijms13078670
AMA Style
Worthmann H, Dengler R, Schumacher H, Schwartz A, Eisert WG, Lichtinghagen R, Weissenborn K.
Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke. International Journal of Molecular Sciences. 2012; 13(7):8670-8678.
https://doi.org/10.3390/ijms13078670
Chicago/Turabian Style
Worthmann, Hans, Reinhard Dengler, Helmut Schumacher, Andreas Schwartz, Wolfgang G. Eisert, Ralf Lichtinghagen, and Karin Weissenborn.
2012. "Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke" International Journal of Molecular Sciences 13, no. 7: 8670-8678.
https://doi.org/10.3390/ijms13078670
APA Style
Worthmann, H., Dengler, R., Schumacher, H., Schwartz, A., Eisert, W. G., Lichtinghagen, R., & Weissenborn, K.
(2012). Monocyte Chemotactic Protein-1 as a Potential Biomarker for Early Anti-Thrombotic Therapy after Ischemic Stroke. International Journal of Molecular Sciences, 13(7), 8670-8678.
https://doi.org/10.3390/ijms13078670